Insys Call Center Employees Lied to Boost Subsys Approvals
As the Insys trial continues, jurors hear testimony from a former call center manager who claims employees were instructed to lie to insurers to win approval of Subsys.
As the Insys trial continues, jurors hear testimony from a former call center manager who claims employees were instructed to lie to insurers to win approval of Subsys.
Two NECC executives in Massachusetts are contesting their guilty verdicts while another two employees face second-degree murder charges in Michigan.
There is no solid evidence that over-the-counter cough medicines work any better than old-fashioned homeopathic remedies.
An Oklahoma trial against opioid manufacturers could act as a benchmark to determine what role the companies play in creating a nationwide epidemic.
Florida pharmacy, AgeVital, is set to pay at least $775,000 to settle a lawsuit alleging fraud brought about by a patient who received unwanted medications.
Judge denies a motion to dismiss a case against three major drug companies over allegations of price gauging and making it too expensive for diabetics to obtain life-saving insulin.
Maryland lawmakers are considering a bill that would list medical marijuana as an effective treatment option for opioid use disorder.
The Food and Drug Administration (FDA) sent a warning letter to drug distributor McKesson for incidents in which pharmacies received tampered with shipments of opioids.
Johnson & Johnson will improve transparency regarding the cost of certain prescriptions by including pricing in television ads.
Protestors flood museums the Sackler family has donated to over the years, asking them to refuse any future funding.